Icon

PROVIGIL (nda020717)- (100MG,200MG)

MODAFINIL CEPHALON
100MG,200MG
Yes No
2024-May-29 Expired
None None
None No
PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD).
7 4 7
Total Other Developers 1
Drugs with Suitability No
100MG ** ** - - 6
200MG ** ** Down - 6
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** *** **** **** *****. ***. **., ***. (******** ***** *******) *********** **, **** **** **.,, ******** ****, *****, ****** (***) ***
****** ****** ****** ****** *************** ******* ******* *********** **** **.** (****) *** ** (****), ****** ********** ****, ***************, *************, ***********, ***** **** ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-*, **. **. ***/*, ***/*, ***/*, **** **. *-*/*, ***** ***, ***** ********** ****, ********* (*******), ********* (******), ************ (********), ************, ********* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ***** ******* ******* ******* ******* *********** **** **. ***, ***, ***, *** & ***, ***** ************** *******, *******, ************, ***** **** ******, ***** (***) ***
****** ***** ****** ************ (*****) ***.***. *********** ****. **. **. **********, ******* ********** ****, *******, ***** *****, ********, *********** ******, ***** (***) ***
****** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.